Buy or sell Viome stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Viome Stock

Discovering predictive biomarkers to eradicate all diseases.

Founded

2016

Headquarters

Cupertino CA, US

Total Funding

$15.0M

About Viome Stock

Viome is a team of leading entrepreneurs, scientists, and physicians. Their proven expertise is why Viome is the only private company trusted with exclusive license to technology first developed at the prestigious Los Alamos National Laboratory. Viome’s pioneering artificial learning engines are designed to not only analyze your data, but to aggregate all the biological data they receive. As the sample size grows, their machines will spot trends and influences, which will unlock scientific breakthroughs.

Funding History

July 2017$15.0M

Management

Founder & President

Deepak Savadatti

Founder & CEO

Naveen Jain

Chief Medical Officer

Helen Messier

Press

Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from Viome or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 70K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo